載入...

Successful afatinib rechallenge in a patient with non‐small cell lung cancer harboring EGFR G719C and S768I mutations

Recent studies have indicated that afatinib is beneficial for patients with non‐small cell lung cancer (NSCLC) harboring uncommon epidermal growth factor receptor (EGFR) mutations, while the effectiveness of afatinib rechallenge has not been fully defined. Here, we report a long‐term survival case o...

全面介紹

Na minha lista:
書目詳細資料
發表在:Thorac Cancer
Main Authors: Masuda, Tomomi, Sunaga, Noriaki, Kasahara, Norimitsu, Takehara, Kazutaka, Yatomi, Masakiyo, Hara, Kenichiro, Koga, Yasuhiko, Maeno, Toshitaka, Hisada, Takeshi
格式: Artigo
語言:Inglês
出版: John Wiley & Sons Australia, Ltd 2020
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7396375/
https://ncbi.nlm.nih.gov/pubmed/32529804
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13532
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!